This gene mutation involves TMX2, TMX2-CTNND1 (thioredoxin related transmembrane protein 2| TMX2-CTNND1 readthrough (NMD candidate)) on Chromosome 11. Is it associated with any clinical condition, or is it benign?
Pathogenic; Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity